Singular Genomics Systems, Inc. (OMIC) Reports In-Line Q4 EPS
Get Alerts OMIC Hot Sheet
Join SI Premium – FREE
Singular Genomics Systems, Inc. (NASDAQ: OMIC) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $829.67 thousand.
For earnings history and earnings-related data on Singular Genomics Systems, Inc. (OMIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Names Top Electrical Equipment Stocks Ahead of Earnings Season
- Citizens Starts Vail Resorts (MTN) at Market Perform
- Educational Development (EDUC) Reports Q2 Loss of $0.19
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share